Letter to the Editor Regarding “Sublingual Immunotherapy Attenuates Nasal Symptoms upon Allergen Exposure in Murine Allergic Rhinitis Model via an Induction of IL-10 producing T cells in Submandibular Lymph Node”
Restricted accessLetterFirst published online January, 2020
Letter to the Editor Regarding “Sublingual Immunotherapy Attenuates Nasal Symptoms upon Allergen Exposure in Murine Allergic Rhinitis Model via an Induction of IL-10 producing T cells in Submandibular Lymph Node”
QuYYamadaTAoiN, et al. Sublingual Immunotherapy Attenuates Nasal Symptoms upon Allergen Exposure in Murine Allergic Rhinitis Model via an Induction of IL-10 producing T cells in Submandibular Lymph Node. Ann Otol Rhinol Laryngol. 2019;128(suppl 6):26S-35S.
2.
BoonpiyathadTCapovaGDuchnaHW, et al. Impact of high altitude therapy on type-2 immune responses in asthma patients [published online July 3, 2019]. Allergy. 2019. doi:10.1111/all.13967
3.
BousquetJVignolaAMDemolyP.Links between rhinitis and asthma. Allergy. 2003;58(8):691-706.
4.
HansenJWThomsenSFNolteH, et al. Rhinitis: a complication to asthma. Allergy. 2010;65(7):883-888.
5.
KaragiannidisCHenseGRueckertB, et al. High-altitude climate therapy reduces local airway inflammation and modulates lymphocyte activation. Scand J Immunol. 2006;63(4):304-310.
